Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
85,780,233
-
Share change
-
-3,615,808
-
Total reported value
-
$10,708,084,374
-
Put/Call ratio
-
71%
-
Price per share
-
$124.89
-
Number of holders
-
454
-
Value change
-
-$609,293,520
-
Number of buys
-
220
-
Number of sells
-
237
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q3 2024
As of 30 Sep 2024,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
454 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,780,233 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Capital International Investors, JANUS HENDERSON GROUP PLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, FARALLON CAPITAL MANAGEMENT LLC, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO, and Bank of New York Mellon Corp.
This page lists
451
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.